Peak6 Investments LLC Biocryst Pharmaceuticals Inc Call Options Transaction History

Peak6 Investments LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 14, 2024	BUY	$4.89 - $7.65 $122,249 - $191,250	25,000 New	25,000 $127,000
Q4 2022 Feb 10, 2023	BUY	$10.5 - $14.2 $319,200 - $431,680	30,400 New	30,400 $349,000
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $129,396 - $293,232	-16,400 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $189,584 - $324,064	16,400 New	16,400 $267,000
Q2 2021 Aug 13, 2021	SELL	$9.5 - $17.24 $475,000 - $861,999	-50,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$7.37 - $13.61 $368,500 - $680,500	50,000 New	50,000 $508,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.45B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.